Hello? Can I speak with someone from the Trump-Kennedy Commission on Childhood Diseases? I believe this is an emergency situation

(This is Part-12 in a series; for Part-13, click here; for Part-11, click here.)

Yes. Thanks for talking to me. This is Jon Rappoport. Are you aware that in the US, every year, there are between 216,000 and 288,000 pregnant women who take SSRI antidepressants?

You aren’t? Well, you should be. Of course, as we know, these drugs produce suicidal ideation. That means people think about killing themselves.

There are many other adverse effects of SSRIs on the babies. Congenital malformations, respiratory distress, Persistent Pulmonary Hypertension, lower birth weight, cognitive motor delays, autism, and so on.

Most researchers conclude these adverse effects are rare and/or mild, but who is conducting the relevant studies? How many studies are run by the companies who manufacture and sell the SSRIs? I think you should look into that.

You see, the FDA has never approved the specific use of SSRIs with pregnant women. That use is considered “off-label,” which means the doctor uses his own discretion in deciding whether a drug is suitable for a patient.

Why hasn’t the FDA approved SSRIs with pregnant women? Look into that, too.

Quite often, we’re told the FDA declined to make an approval because it doesn’t have enough data. In the case of drugs and pregnant women, this can mean pregnant women were excluded from clinical trials, because enrolling them was considered unethical. Dangerous.

Let’s see. Testing a drug on pregnant women is unethical, but doctors can decide to prescribe that drug for pregnant women. You’d better look into that, too.